A recent population-based study, published in CANCER, a peer-reviewed journal of the American Cancer Society, has brought into sharp focus…
Read More
Researchers Develop Novel Vitamin K Analogues as Potential Regenerative Therapy for Neurodegenerative Diseases
Researchers at the Shibaura Institute of Technology (SIT) in Japan have developed a novel vitamin K analogue that demonstrates significantly…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read More
A Groundbreaking Macrophage Therapy Shows Promise for End-Stage Liver Disease Patients
Scientists at the University of Edinburgh have unveiled promising results from the MATCH clinical trial, demonstrating the potential of a…
Read More
Datroway Receives FDA Approval for Metastatic Triple-Negative Breast Cancer, Marking a Significant Advancement in Targeted Therapy
The US Food and Drug Administration (FDA) has granted a pivotal approval for Datroway (datopotamab deruxtecan), a novel antibody-drug conjugate…
Read More
Novel Combination Therapy Offers Breakthrough Strategy for Overcoming Differentiation Blockade in Acute Myelogenous Leukemia
Acute Myelogenous Leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by its rapid progression and…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The study, conducted by researchers analyzing extensive data from the Osaka Cancer Registry in Japan, provides a robust and concerning…
Read More
Groundbreaking Stem Cell Therapy Shows Promise in Reversing Type 1 Diabetes in Mice, Offering New Hope for Patients
Scientists from Stockholm, Sweden, affiliated with Karolinska Institutet and KTH Royal Institute of Technology, have reported a significant advancement in…
Read More
VERTANICAL’s Investigational Non-Opioid Chronic Low Back Pain Treatment VER-01 Receives FDA Breakthrough Therapy Designation
VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
Novo Nordisk Hands a Parkinson’s Cell Therapy to Cellular Intelligence, a Startup Trying to Design Cell Behavior
In a significant move poised to reshape the landscape of Parkinson’s disease treatment and the broader cell therapy sector, Cellular…
Read More
